Lucie Thomas

Lucie Thomas

Auto-generated profile, based on publicly available information

Lucie Thomas

INSERM U933, Childhood Genetic Diseases, Sorbonne Université, Hôpital Armand-Trousseau , Paris

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
MWMarjorie Whitfield
Marjorie Whitfield
LTLucie Thomas
Lucie Thomas
EBEmilie Bequignon
Emilie Bequignon
ASAlain Schmitt
Alain Schmitt
LSLaurence Stouvenel
Laurence Stouvenel
MLMarie Legendre
Marie Legendre

8 February 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
COChiara Olcese
Chiara Olcese
MPMitali P. Patel
Mitali P. Patel
ASAmelia Shoemark
Amelia Shoemark
SKSanteri Kiviluoto
Santeri Kiviluoto
MLMarie Legendre
Marie Legendre
KWKlaudia Walter
Klaudia Walter
By moving essential body fluids and molecules, motile cilia and flagella govern respiratory mucociliary clearance, laterality determination and the transport of gametes and cerebrospinal fluid. Primary ciliary dyskinesia (PCD) is an autosomal recessive disorder frequently caused by non-assembly of dynein arm motors into cilia and flagella axonemes. Before their import into cilia and flagella, multi-subunit axonemal dynein arms are thought to be stabilized and pre-assembled in the cytoplasm through a DNAAF2–DNAAF4–HSP90 complex akin to the HSP90 co-chaperone R2TP complex. Here, we demonstrate that large genomic deletions as well as point mutations involving PIH1D3 are responsible for an X-linked form of PCD causing disruption of early axonemal dynein assembly. We propose that PIH1D3, a protein that emerges as a new player of the cytoplasmic pre-assembly pathway, is part of a complementary conserved R2TP-like HSP90 co-chaperone complex, the loss of which affects assembly of a subset of inner arm dyneins.

1 December 2018 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
MFMahmoud R. Fassad
Mahmoud R. Fassad
ASAmelia Shoemark
Amelia Shoemark
MLMarie Legendre
Marie Legendre
RHRobert A. Hirst
Robert A. Hirst
FKFrance Koll
France Koll
HMHannah M. Mitchison
Hannah M. Mitchison

1 August 2016 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
EKElma El Khouri
Elma El Khouri
LTLucie Thomas
Lucie Thomas
LJLudovic Jeanson
Ludovic Jeanson
EBEMILIE BEQUIGNON
EMILIE BEQUIGNON
BVBenoit Vallette
Benoit Vallette
SASerge Amselem
Serge Amselem

8 October 2015 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
ZAZuzanna Andrzejewska
Zuzanna Andrzejewska
NNNathalie Nevo
Nathalie Nevo
LTLucie Thomas
Lucie Thomas
CCCerina Chhuon
Cerina Chhuon
ABAnne Bailleux
Anne Bailleux
CACorinne Antignac
Corinne Antignac
Cystinosis is a rare autosomal recessive storage disorder characterized by defective lysosomal efflux of cystine due to mutations in the CTNS gene encoding the lysosomal cystine transporter, cystinosin. Lysosomal cystine accumulation leads to crystal formation and functional impairment of multiple organs. Moreover, cystinosis is the most common inherited cause of renal Fanconi syndrome in children. Oral cysteamine therapy delays disease progression by reducing intracellular cystine levels. However, because cysteamine does not correct all complications of cystinosis, including Fanconi syndrome, we hypothesized that cystinosin could have novel roles in addition to transporting cystine out of the lysosome. By coimmunoprecipitation experiments and mass spectrometry, we found cystinosin interacts with almost all components of vacuolar H+-ATPase and the Ragulator complex and with the small GTPases Ras-related GTP-binding protein A (RagA) and RagC. Furthermore, the mammalian target of rapamycin complex 1 (mTORC1) pathway was downregulated in proximal tubular cell lines derived from Ctns−/− mice. Decrease of lysosomal cystine levels by cysteamine did not rescue mTORC1 activation in these cells, suggesting that the downregulation of mTORC1 is due to the absence of cystinosin rather than to the accumulation of cystine. Our results show a dual role for cystinosin as a cystine transporter and as a component of the mTORC1 pathway, and provide an explanation for the appearance of Fanconi syndrome in cystinosis. Furthermore, this study highlights the need to develop new treatments not dependent on lysosomal cystine depletion alone for this devastating disease.

1 February 2019 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
XMXimena M Bustamante Marin
Ximena M Bustamante Marin
WYWei-Ning Yin
Wei-Ning Yin
PSPatrick R. Sears
Patrick R. Sears
MWMichael E. Werner
Michael E. Werner
EBEva J. Brotslaw
Eva J. Brotslaw
LOLawrence Ostrowski
Lawrence Ostrowski